Deprescribing in Older Adults | Geriatric Pharmacotherapy [SIMCON 2023]

Added:

A Case Study
Defining Deprescribing
Why Older Adults
Benefits of Stopping
Changing Risk-Benefit
The Process Steps
Planning and Tapering
Barriers to Action
Key Conclusions

A Case Study

2:06
Playing Section
  • 1

    An 82-year-old man developed excessive drowsiness and mobility issues after multiple new medications were added for a leg ulcer.

  • 2

    Stopping three sedative drugs led to a rapid recovery, highlighting the dangers of polypharmacy in older adults.

Understanding the physiological changes of aging and their impact on pharmacokinetics and pharmacodynamics.
The definition and clinical implications of polypharmacy and potentially inappropriate medications (PIMs) in older adults.
Familiarity with geriatric prescribing screening tools, specifically the Beers Criteria and STOPP/START criteria.
Basic knowledge of adverse drug events (ADEs) and drug-drug or drug-disease interactions in the elderly.
Developing patient-centered communication and shared decision-making strategies for tapering or stopping medications.
Managing withdrawal syndromes, rebound effects, and physiological monitoring during the tapering process.
Clinical application of disease-specific deprescribing algorithms (e.g., for proton pump inhibitors, benzodiazepines, or antihypertensives).
Designing and implementing interprofessional deprescribing protocols in outpatient, inpatient, or long-term care settings.
339 views12likes22:40@srilankacollegeofinternalm4691Original Release: 2023-12-21

Deprescribing is a proactive clinical process of medication withdrawal with provisions to restart if needed, supervised by healthcare professionals, aimed at managing polypharmacy and improving outcomes in older adults who are at greater risk of potentially inappropriate prescribing due to multiple comorbidities, different medicine handling, limited psychological reserve, and increased adverse drug reaction risk; the process involves three key steps: obtaining comprehensive patient information about current medications and their impact, identifying drugs that can be deprescribed (those without indication, causing harm, or where benefits no longer outweigh risks), and planning a gradual withdrawal strategy with ongoing communication and monitoring to prevent adverse drug withholding events.